The Latest Headlines at American Banking and Market News
Netflix (NASDAQ:NFLX) Stock Price Down 0.4% Following Insider Selling
Netflix, Inc. (NASDAQ:NFLX – Get Free Report) shares fell 0.4% on Friday after an insider sold shares in the company. The stock traded as low as $608.01 and last traded at $609.94. 1,012,142 shares changed hands during mid-day... More of this article »
JFrog (NASDAQ:FROG) Shares Gap Down After Analyst Downgrade
JFrog Ltd. (NASDAQ:FROG – Get Free Report)’s stock price gapped down before the market opened on Friday after KeyCorp lowered their price target on the stock from $52.00 to $46.00. The stock had previously closed at $40.62,... More of this article »
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down on Analyst Downgrade
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) gapped down prior to trading on Friday after Citigroup lowered their price target on the stock from $62.00 to $60.00. The stock had previously closed at $42.49,... More of this article »
Synaptics (NASDAQ:SYNA) Shares Gap Down Following Analyst Downgrade
Synaptics Incorporated (NASDAQ:SYNA – Get Free Report)’s share price gapped down prior to trading on Friday after Wells Fargo & Company lowered their price target on the stock from $115.00 to $95.00. The stock had... More of this article »
Uber Technologies (NYSE:UBER) Shares Down 1.1% on Analyst Downgrade
Uber Technologies, Inc. (NYSE:UBER – Get Free Report)’s stock price fell 1.1% during trading on Friday after UBS Group lowered their price target on the stock from $100.00 to $95.00. UBS Group currently has a buy rating... More of this article »
Rigetti Computing (NASDAQ:RGTI) Shares Down 7.8% on Disappointing Earnings
Rigetti Computing, Inc. (NASDAQ:RGTI – Get Free Report) was down 7.8% during mid-day trading on Friday following a weaker than expected earnings announcement. The stock traded as low as $1.16 and last traded at $1.18. Approximately... More of this article »
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 to $95.00. Oppenheimer currently has an outperform rating... More of this article »
Montauk Renewables (NASDAQ:MNTK) Shares Gap Up on Earnings Beat
Montauk Renewables, Inc. (NASDAQ:MNTK – Get Free Report) shares gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $4.20, but opened at $4.39. Montauk... More of this article »
Kolibri Global Energy (KGEI) to Release Earnings on Monday
Kolibri Global Energy (NASDAQ:KGEI – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Monday, May 13th. Analysts expect Kolibri Global Energy to post earnings of $0.11 per share for... More of this article »
OmniAb (NASDAQ:OABI) Shares Gap Down Following Weak Earnings
OmniAb, Inc. (NASDAQ:OABI – Get Free Report) shares gapped down before the market opened on Friday following a dissappointing earnings announcement. The stock had previously closed at $4.57, but opened at $4.41. OmniAb shares... More of this article »
Citigroup Boosts Wynn Resorts (NASDAQ:WYNN) Price Target to $138.00
Wynn Resorts (NASDAQ:WYNN – Free Report) had its target price boosted by Citigroup from $132.00 to $138.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the casino... More of this article »
Intellicheck (IDN) to Release Earnings on Monday
Intellicheck (NYSE:IDN – Get Free Report) is set to release its earnings data after the market closes on Monday, May 13th. Analysts expect Intellicheck to post earnings of ($0.04) per share for the quarter. Persons interested... More of this article »
Vaxart (VXRT) to Release Quarterly Earnings on Monday
Vaxart (NASDAQ:VXRT – Get Free Report) is scheduled to release its earnings data after the market closes on Monday, May 13th. Analysts expect Vaxart to post earnings of ($0.16) per share for the quarter. Investors interested... More of this article »